606 Current Genomics, 2010, Vol. 11, No. 8 [73] [74] [75] [76] [77] [78] [79] [80] [81] and improves survival after experimental myocardial infarction through ST2 signaling. Circ. Heart Fail, 2009, 2(6), 684-691. Weinberg, E. O.; Shimpo, M.; Hurwitz, S.; Tominaga, S.-i.; Rouleau, J.-L.; Lee, R. T. Identification of serum soluble ST2 re- ceptor as a novel heart failure biomarker. Circulation, 2003, 107(5), 721-726. Bartunek, J.; Delrue, L.; Van Durme, F.; Muller, O.; Casselman, F.; De Wiest, B.; Croes, R.; Verstreken, S.; Goethals, M.; de Raedt, H.; Sarma, J.; Joseph, L.; Vanderheyden, M.; Weinberg, E. O. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J. Am. Coll. Cardiol., 2008, 52(25), 2166-2174. Shah, R. V.; Chen-Tournoux, A. A.; Picard, M. H.; van Kimme- nade, R. R. J.; Januzzi, J. L. Serum levels of the interleukin-1 re- ceptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circulation, 2009, 2(4), 311-319. Dieplinger, B.; Gegenhuber, A.; Kaar, G.; Poelz, W.; Haltmayer, M.; Mueller, T. Prognostic value of established and novel biomark- ers in patients with shortness of breath attending an emergency de- partment. Clin. Biochem., 2010, 43(9), 714-719. Boisot, S.; Beede, J.; Isakson, S.; Chiu, A.; Clopton, P.; Januzzi, J.; Maisel, A. S.; Fitzgerald, R. L. Serial Sampling of ST2 Predicts 90- Day Mortality Following Destabilized Heart Failure. J. Card. Fail., 2008, 14(9), 732-738. Shimpo, M.; Morrow, D. A.; Weinberg, E. O.; Sabatine, M. S.; Murphy, S. A.; Antman, E. M.; Lee, R. T. Serum Levels of the In- terleukin-1 Receptor Family Member ST2 Predict Mortality and Clinical Outcome in Acute Myocardial Infarction. Circulation, 2004, 109(18), 2186-2190. Pascual-Figal, D. A.; Ordoñez-Llanos, J.; Tornel, P. L.; Vázquez, R.; Puig, T.; Valdés, M.; Cinca, J.; de Luna, A. B.; Bayes-Genis, A. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J. Am. Coll. Cardiol., 2009, 54(23), 2174-2179. Moore, S. A.; Januzzi Jr, J. L. Found in Translation: Soluble ST2 and Heart Disease. J. Am. Coll. Cardiol., 2010, 55(3), 251-253. Weir, R. A. P.; Miller, A. M.; Murphy, G. E. J.; Clements, S.; Steedman, T.; Connell, J. M. C.; McInnes, I. B.; Dargie, H. J.; [82] [83] [84] [85] [86] [87] [88] [89] Akhabir and Sandford McMurray, J. J. V. Serum Soluble ST2: A Potential Novel Media- tor in Left Ventricular and Infarct Remodeling After Acute Myo- cardial Infarction. J. Am. Coll. Cadiol., 2010, 55(3), 243-250. Hoogerwerf, J.; Tanck, M.; Van Zoelen, M.; Wittebole, X.; Laterre, P.; Van der Poll, T. Soluble ST2 plasma concentrations predict mortality in severe sepsis. Intensive Care Med., 2010, 36(4), 630-7. Baker, C.; Chaudry, I.; Gaines, H.; Baue, A. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery, 1983, 94(2), 331-5. Jones, L. A.; Roberts, F.; Nickdel, M. B.; Frank, B.; McKenzie, A. N. J.; Henriquez, F. L.; Alexander, J.; Roberts, C. W. IL-33 recep- tor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur. J. Immunol., 2010, 40(2), 426-436. Dhiman, N.; Ovsyannikova, I. G.; Vierkant, R. A.; Pankratz, V. S.; Jacobson, R. M.; Poland, G. A. Associations between cyto- kine/cytokine receptor single nucleotide polymorphisms and hu- moral immunity to measles, mumps and rubella in a Somali popu- lation. Tissue Antigens, 2008, 72(3), 211-20. Imada, Y.; Fujimoto, M.; Hirata, K.; Hirota, T.; Suzuki, Y.; Saito, H.; Matsumoto, K.; Akazawa, A.; Katsunuma, T.; Yoshihara, S.; Ebisawa, M.; Shibasaki, M.; Arinami, T.; Tamari, M.; Noguchi, E. Large scale genotyping study for asthma in the Japanese popula- tion. BMC Res. Notes, 2009, 2(1), 54. Humphreys, N. E.; Xu, D.; Hepworth, M. R.; Liew, F. Y.; Grencis, R. K. IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes. J. Immunol., 2008, 180(4), 2443-2449. Saito, T.; Ji, G.; Shinzawa, H.; Okumoto, K.; Hattori, E.; Adachi, T.; Takeda, T.; Sugahara, K.; Ito, J.-i.; Watanabe, H.; Saito, K.; Togashi, H.; Ishii, K.; Matsuura, T.; Inageda, K.; Muramatsu, M.; Kawata, S. Genetic variations in humans associated with differ- ences in the course of hepatitis C. Biochem. Biophys. Res. Com- mun., 2004, 317(2), 335-341. Marvie, P.; Lisbonne, M.; L'Helgoualc'h, A.; Rauch, M.; Turlin, B.; Preisser, L.; Bourd-Boittin, K.; Théret, N.; Gascan, H.; Piquet- Pellorce, C.; Samson, M. Interleukin-33 overexpression is associ- ated with liver fibrosis in mice and humans. J. Cell. Mol. Med., 2010, 14(68), 1726-39.